Filing Details

Accession Number:
0001140361-17-008482
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-22 13:49:27
Reporting Period:
2017-02-21
Filing Date:
2017-02-22
Accepted Time:
2017-02-22 13:49:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
730708 Seacoast Banking Corp Of Florida SBCF State Commercial Banks (6022) 592260678
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1091449 W John Rose C/O Capgen Capital Group Iii Lp
120 West 45Th Street, Suite 1010
New York NY 10036
Yes No Yes No
1228649 Robert Goldstein C/O Capgen Capital Group Iii Lp
120 West 45Th Street, Suite 1010
New York NY 10036
No No Yes No
1453863 Eugene Ludwig C/O Capgen Capital Group Iii Lp
120 West 45Th Street, Suite 1010
New York NY 10036
Yes No Yes No
1488107 Capgen Capital Group Iii Lp 120 West 45Th Street, Suite 1010
New York NY 10036
Yes No Yes No
1488108 Capgen Capital Group Iii Llc C/O Capgen Capital Group Iii Lp
120 West 45Th Street, Suite 1010
New York NY 10036
Yes No Yes No
1503574 P John Sullivan C/O Capgen Capital Group Iii Lp
120 West 45Th Street, Suite 1010
New York NY 10036
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.10 Per Share Disposition 2017-02-21 6,210,000 $22.25 1,253,141 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.10 Per Share 52,985 Direct
Common Stock, Par Value $0.10 Per Share 12,437 Indirect See footnote.
Common Stock, Par Value $0.10 Per Share 9,950 Direct
Common Stock, Par Value $0.10 Per Share 49,373 Direct
Footnotes
  1. CapGen Capital Group III LP ("CapGen III") sold 6,210,000 shares of common stock, par value $0.10 per share ("Common Stock"), of Seacoast Banking Corporation of Florida (the "Issuer") in an underwritten public offering by Issuer and CapGen III, which closed on February 21, 2017.
  2. The sale price reflects the public offering price. The price received by the reporting person will be $21.02625 per share, which is net of an underwriting discount of $1.22375 per share.
  3. CapGen Capital Group III LLC ("CapGen LLC"), as the sole general partner of CapGen III, may be deemed to be an indirect beneficial owner of the shares in this row under Rule 16a-1(a)(2) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Pursuant to Rule 16a-1(a)(4) promulgated under the Exchange Act, CapGen LLC disclaims that it is the beneficial owner of such shares, except to the extent of its pecuniary interest.
  4. Each of Mr. Ludwig, as the managing member of CapGen LLC, Mr. Sullivan, as a member of the investment committee of CapGen LLC, and Mr. Goldstein and Mr. Rose, as principal members and members of the investment committee of CapGen LLC, may be deemed to be an indirect beneficial owner of the shares in this row pursuant to Rule 16a-1(a)(2) promulgated under the Exchange Act.
  5. Pursuant to Rule 16a-1(a)(4) promulgated under the Exchange Act, each of Mr. Ludwig, Mr. Sullivan, Mr. Rose and Mr. Goldstein disclaims that he is the beneficial owner of the shares in this row, except to the extent of his pecuniary interest.
  6. Mr. Goldstein directly owns the shares reported in this row.
  7. The shares reported in this row are held in a retirement account over which Mr. Goldstein holds discretionary authority.
  8. Mr. Sullivan directly owns the shares reported in this row.
  9. Mr. Rose directly owns the shares reported in this row.